Single course of Covid-19 treatment to cost $2,340 per patient - Gilead
(Sharecast News) - Gilead Sciences has announced it will charge developed countries $390 a vial for remdesivir, its antiviral drug currently being investigated for use in Covid-19 patients.
Read more